Home
Search
BIO Investor Forum    |   October 15-16, 2024

Speakers & Presenters

All Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Anne-Marie Carbonell, MD
CO-FOUNDER & CEO, ONCOSYNERGY, INC.
OncoSynergy, Inc
Greenwich, Connecticut, United States
photo
Will Chou
CEO, ARUVANT SCIENCES, INC.
Aruvant
New York, New York, United States
photo
Charles "Chuck" Calderaro
SENIOR VICE PRESIDENT AND GLOBAL HEAD OF TECHNICAL OPERATIONS, KITE, A GILEAD COMPANY
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
photo
Diana Caldwell
CEO AND PRESIDENT, AMPLIFIED SCIENCES, LLC
Amplified Sciences
West Lafayette, Indiana, United States
photo
Ray Camphausen, PHD
CEO, WAYLAND BIOTHERAPEUTICS, LLC
Wayland Biotherapeutics LLC
Wayland, Massachusetts, United States
photo
Anne-Marie Carbonell, MD
CO-FOUNDER AND CEO, ONCOSYNERGY
Trends in New Oncology Target Treatments
photo
Karen Carey
NEWS ANALYST, BIOWORLD TODAY
Conducting Remote Clinical Trials Productively During a Pandemic
York, Pennsylvania, United States
photo
John Carpten
PROFESSOR AND CHAIR OF TRANSLATIONAL GENOMICS;DIRECTOR, INSTITUTE OF TRANSLATIONAL GENOMICS, KECK SCHOOL OF MEDICINE, USC
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Los Angeles, California, United States
photo
Patrizia Cavazzoni, MD
DEPUTY DIRECTOR FOR OPERATIONS, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Fireside Chat: Patrizia Cavazzoni, MD, Acting Director for Center for Drug Evaluation and Research (CDER) and Deputy Center Director for Operations, U.S. Food and Drug Administration (FDA)
Silver Spring, Maryland, United States
photo
Howard Chen
MANAGING PRINCIPAL, MANAGEMENT CONSULTING, IQVIA CHINA
China Deal-Making Now: New Opportunities and Barriers
Jing'an District, Shanghai, China
photo
Jung Choi
CHIEF BUSINESS & STRATEGY OFFICER, GLOBAL BLOOD THERAPEUTICS
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
South San Francisco, California, United States
photo
Guy Cipriani
CBO, MICROBION CORPORATION
Microbion Corporation
Bozeman, Montana, United States
photo
Steve Clemons
EDITOR-AT-LARGE, THE HILL
Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19
Washington, District of Columbia, United States
photo
Matt Coffey
CEO, ONCOLYTICS BIOTECH
Oncolytics Biotech
Calgary, Alberta, Canada
photo
Asha Collins, PHD
HEAD OF COUNTRY CLINICAL OPERATIONS, GENENTECH, A MEMBER OF THE ROCHE GROUP
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
South San Francisco, California, United States
photo
Grace Colon, PHD
PRESIDENT & CEO, INCARDA THERAPEUTICS INC.
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
Newark, California, United States
photo
David Coman
CEO, SCIENCE 37
Conducting Remote Clinical Trials Productively During a Pandemic
Los Angeles, California, United States
photo
Kevin Conroy, JD
CHAIRMAN AND CEO, EXACT SCIENCES CORPORATION
New Directions in Diagnostics Innovation
Madison, Wisconsin, United States
photo
Pamela Contag, PHD
CHIEF EXECUTIVE OFFICER, BIOECLIPSE THERAPEUTICS, INC.
BioEclipse Therapeutics
Mountain View, California, United States
photo
Helena Cowley, MBA, MS
CEO, OXIDIEN PHARMACEUTICALS, LLC
Oxidien Pharmaceuticals
Gainesville, Florida, United States
photo
David Crean, PHD, MBA
MANAGING DIRECTOR, OBJECTIVE CAPITAL PARTNERS, LLC
View from the Board: Managing Teams During a Pandemic
San Diego, California, United States
photo
William Crossman
PRESIDENT & CEO, PHOENIX PHARMALABS, INC
Phoenix PharmaLabs, Inc.
Woods Cross, Utah, United States
photo
Max Cynader
CEO, PRIMARY PEPTIDES INC
Primary Peptides Inc
Vancouver, British Columbia, Canada
Load More